SILAS LUNA: Open Payments
NPI 1003395872 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 21 payments from 8 companies in 2025. Trend: 2023 $244 · 2024 $92 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $232 |
| Calyxo, Inc. | 2 | $187 |
| Olympus America Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| 180 Medical, Inc. | 1 | $28 |
| UROGEN PHARMA, INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: CVAC ASPIRATION SYSTEM, GEMTESA, ORGOVYX, iTIND System, KEYTRUDA, PLUVICTO, LUPRON DEPOT.
Industry payments across TX — which companies pay providers there.
